Shamsali Rezazadeh - Concepedia

Author

Shamsali Rezazadeh

Academic Center for Education, Culture and Research

Also Known As

Shams-Ali Rezazadeh, Shamsali REZAZADEH, Shamsali Rezazadeh, Shams‐Ali Rezazadeh

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Academic Center for Education, Culture and Research Tehran University of Medical Sciences Roozbeh Hospital Hafez Hospital Kurdistan University of Medical Sciences

About

Shamsali Rezazadeh is an author at Academic Center for Education, Culture and Research specializing in medicine, pharmacology, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	867
2	Social Sciences	4	4	279
3	Engineering	2	2	71
4	Education	1	1	115
5	Health Sciences	1	1	31

Shamsali Rezazadeh

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease Shahin Akhondzadeh, Mehdi Shafiee Sabet, Mohammad Hossein Harirchian, Psychopharmacology Neurodegenerative DiseasesAlzheimer's DiseaseMedicineBrain HealthNeuroscience	2009	256
Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder Vala Rezaei, Mohammad-Reza Mohammadi, Ahmad Ghanizadeh, Progress in Neuro-Psychopharmacology and Biological Psychiatry PsychiatryAllergy MedicinePsychotropic MedicationPediatricsEducation	2010	115
Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism Shahin Akhondzadeh, Jalil Fallah, Mohammad-Reza Mohammadi, Progress in Neuro-Psychopharmacology and Biological Psychiatry PsychiatryMedicineAutismChild PsychiatryDevelopmental Disorder	2009	101
Ginkgo biloba for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized controlled trial Bahman Salehi, Reza Imani, Mohammad Reza Mohammadi, Progress in Neuro-Psychopharmacology and Biological Psychiatry AdhdPsychiatryPediatricsSocial SciencesAttention	2009	86
Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: A double-blind randomized placebo-controlled study Shahin Akhondzadeh, Mojgan Malek-Hosseini, Abolfazl Ghoreishi, Progress in Neuro-Psychopharmacology and Biological Psychiatry PsychiatryPsychotic DisorderAddictionMedicinePsychopharmacology	2008	75
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial Seyed-Hesameddin Abbasi, Haleh Behpournia, Aboulfazl Ghoreshi, Schizophrenia Research PsychiatryPsychotic DisorderPsychotropic MedicationPharmacologyPsychopharmacology	2009	73
Suppression of nitric oxide production in activated murine peritoneal macrophages in vitro and ex vivo by Scrophularia striata ethanolic extract Abbas Azadmehr, Afshin Afshari, Behzad Baradaran, Journal of Ethnopharmacology InflammationNitric Oxide ProductionAnti-inflammatoryReactive Nitrogen SpecieMedicine	2009	65
A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders Elmira Hasanzadeh, Mohammad-Reza Mohammadi, Ahmad Ghanizadeh, Child Psychiatry & Human Development Autistic DisordersGinkgo Biloba AddedPsychiatryMedicinePsychotropic Medication	2012	55
Fabrication, characterization and optimization of berberine-loaded PLA nanoparticles using coaxial electrospray for sustained drug release Reza Ghaffarzadegan, Sepideh Khoee, Shamsali Rezazadeh DARU Journal of Pharmaceutical Sciences NanoparticlesNanomedicineEngineeringNanomaterialsPharmaceutical Nanotechnology	2020	48
Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial Ali‐Reza Zarinara, Mohammad‐Reza Mohammadi, Nazanin Hazrati, Human Psychopharmacology Clinical and Experimental	2010	47

Page 1